	Development of a Nomogram Incorporating Multiparametric MRI and Clinical Indicators for Predicting Positive Surgical Margins After Radical Prostatectomy. Arch Esp Urol Ma J, Qiu X, Ren F, Hu Y, Cui Q, Zhou X. PMID: 42608364 [PubMed - indexed for MEDLINE]
	Cancer-Associated Thrombosis in Genitourinary Malignancies: A Real-World Analysis From the TESEO Registry. Arch Esp Urol Pelegrín-Mateo FJ, Grau Mirete B, Vázquez Mazón F, Rodríguez Lescure Á, Jiménez Fonseca P, Carmona Bayonas A, Fernández Pérez I, Rubio Pérez J, Ortega Morán L, Cacho Lavin D, Martínez Del Prado P, Martínez Marín M, García de Herreros M, Carmona Campos M, Muñoz Martín A. PMID: 42608360 [PubMed - indexed for MEDLINE]
	Bone Health in Patients With Prostate Cancer Treated With Androgen Deprivation Therapy: Risk Assessment and Practical Recommendations. Arch Esp Urol Guardado González S, López-Campos F, Gaztañaga Boronat M, Fernández Alonso S, Zaragoza Cocero L, Glaría Enríquez LA, Gómez-Aparicio MA, Rodríguez-Izquierdo Jiménez M, García Tello A, Le Guévelou J, Couñago F. PMID: 42608357 [PubMed - in process]
	Reply to Pietro scilipoti, Giuseppe Rosiello, Andrea Salonia, Alberto Briganti, Marco Moschini, Francesco Montorsi Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Contieri R, Hurle R. PMID: 42608213 [PubMed - as supplied by publisher]
	Developing an individualised prostate biopsy algorithm in patients with PI-RADS â‰¥3 lesions: a prospective multicentre cohort study protocol in China. BMJ Open Tang J, Zhang Z, Yu Z, Xing Y, Luo J, Chen J, Zeng S, Zheng X, Zheng Q, Bi L, Wu T. PMID: 42608035 [PubMed - indexed for MEDLINE]
	Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304). Ann Oncol Zhang AY, Thomas H, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Herberstein C, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McLaughlin RA, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Zielinski RR, Stockler MR, Davis ID, Sweeney CJ. PMID: 42607762 [PubMed - as supplied by publisher]
	Post-Diagnostic Red Meat, Poultry, and Egg Intake and Risk of Prostate Cancer Progression and Mortality: A Systematic Review. J Urol Sandhu S, Teshome H, Van Blarigan EL, Chan JM, Kenfield SA, Graff RE. PMID: 42607142 [PubMed - as supplied by publisher]
	A comprehensive framework for multi-class prostate cancer classification using biparametric MRI: a multi-center retrospective study. Insights Imaging Zheng B, Yang Y, Maheremu M, Bao L, Zhang L, Qin G, Liao Z, Lv S, Tao J, Xiang Y, Wei Q. PMID: 42606778 [PubMed]
	A bibliometric analysis of the robotic revolution in prostate cancer surgery: evolution, hotspots, and future directions. J Robot Surg Zhang X, Wang L, Peng Y, Jin J, Cai Y, Luo X. PMID: 42606766 [PubMed - indexed for MEDLINE]
	Global research trends in pelvic lymph node dissection during robot-assisted radical prostatectomy: a bibliometric and knowledge-mapping analysis. J Robot Surg Chen X, Sairah AK, Wu T. PMID: 42606641 [PubMed - indexed for MEDLINE]
	Bladder preservation vs. radical cystectomy for T2N0M0: trends and survival outcomes from SEER. World J Urol He Q, Jiang Z, Jiang C, Tu X, Huang J. PMID: 42606609 [PubMed - indexed for MEDLINE]
	Common Male Genitourinary Issues: Prostate Cancer Screening and Treatment. FP Essent Saffold JJ MD. PMID: 42606508 [PubMed - indexed for MEDLINE]
	Concurrent Adenoid Cystic/Basal Cell Carcinoma and Acinar Adenocarcinoma of the Prostate: Comprehensive Molecular Analysis of Both Tumor Component. Int J Surg Pathol Pivovarcikova K, Alaghehbandan R, Bradova M, Ptakova N, Martinek P, Vanecek T, Michal M, Fiala O, Hora M, Ondic O. PMID: 42606337 [PubMed - as supplied by publisher]
	Enzalutamide-Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration-Resistant Prostate Cancer: A Hypothesis-Generating Study. Clin Pharmacol Ther Corona G, Visentin M, Samodelov SL, Maines F, Caffo O, Miolo G. PMID: 42606154 [PubMed - as supplied by publisher]
	Association of Postoperative Antidepressant and Anxiolytic Exposure With Overall Survival Following Radical Cystectomy for Bladder Cancer. Psychooncology Huang CS, Tung KH, Wu YS, Yu CP, Yu DS, Yang MH, Lee YE, Ho JY. PMID: 42606027 [PubMed - indexed for MEDLINE]
	Artificial intelligence for predicting BCG response in non-muscle-invasive bladder cancer: a systematic review. BJU Int Cella L, Contieri R, Paciotti M, Fasulo V, Uleri A, Avolio PP, Mertens LS, Pradere B, Perdonà S, Saita A, Lazzeri M, Casale P, Lughezzani G, Hurle R, Buffi NM. PMID: 42605566 [PubMed - as supplied by publisher]
	Editorial Comment to Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter Study. Int J Urol Okumi M. PMID: 42605512 [PubMed - in process]
	When to Intervene in Renal Masses: Integrating Tumor Biology, Patient Fitness, and Competing Mortality Into Clinical Decision-Making. Cureus Buali HF, Albenjasim K, Al Shaibani A, Aljeeran N, Rafie M. PMID: 42605385 [PubMed]
	Advances in NIR-II Fluorescence Laparoscopy for Precision Diagnosis and Theranostics of Urological Oncology. Int J Nanomedicine Liu Q, Li S, Xu M, Rong S, Wei Y, Li J, Jia F, Li S, Zhang H, He J, Liu C, Yang X. PMID: 42605362 [PubMed - indexed for MEDLINE]
	Flexible intervention workflow for MRI guided robotic prostate seed brachytherapy. J Appl Clin Med Phys Aumueller P, Dannert ML, Polednik M, Giordano FA, Fleckenstein J, Clausen S. PMID: 42605022 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180771

Page 1 of 9039



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy